Kara J. Wright

FDA investigator

Appears on 9 documents from 2024 to 2026, most often at sites in Ohio. Most often cites control of microbiological contamination (21 CFR 211.113).

9
Documents on file
6.9
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 50 observations

Activity by year

2024: 3, 2025: 3, 2026: 3

Where

Ohio 2 · Pennsylvania 2 · California 1 · Georgia 1 · Indiana 1 · New York 1

Is Kara J. Wright coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 RC Outsourcing, LLCSep 3, 2026 · Lowellville, Ohio
483 XeCare LLCJun 17, 2026 · New Albany, Ohio
483 Gateway Analytical, LLCMar 20, 2026 · Gibsonia, Pennsylvania
483 Eli Lilly and CompanyMay 20, 2025 · Indianapolis, Indiana
483 PCI San Diego, Inc.May 9, 2025 · San Diego, California
483 Janssen Pharmaceuticals, Inc.Jan 24, 2025 · Athens, Georgia
483 Calumet Karns City Refining LLCDec 4, 2024 · Karns City, Pennsylvania

About this profile

What does Kara J. Wright inspect?

Kara J. Wright appears on 9 documents on file covering 9 sites, most often in Ohio.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Kara J. Wright is dated Sep 3, 2026.